Trinity Press Releases

Boston, MA, May 15, 2018 – Trinity, a leading global life sciences consulting firm, today announced it will attend several important industry events across the U.S. this month. Covering topics ranging from innovation and endocrinology research to managed care, Trinity leaders...

Boston, MA, April 10, 2018 – Trinity, a leading global life sciences consulting firm, today announced it will participate in eyeforpharma’s 16th Annual Meeting, April 10-11, in Philadelphia, PA. This year’s eyeforpharma meeting is designed to provide life sciences executives with...

Rare Disease Day falls on Wednesday, February 28th. At Trinity, we work closely with many life sciences companies developing treatments for rare disease patients. Research is crucial to the rare community, and we are committed to help raise awareness around the...

In a recent article for Managed Healthcare Executive, editor Tracey Walker spoke with Trinity’s Jillian Godfrey Scaife about the findings of Trinity’s recent biosimilar whitepaper. In the article, Jillian highlights key takeaways from the findings. You can read the full story...

Complex Pricing Structures, Legal and Regulatory Barriers, and Clinical Uncertainty Hinder Progress in Biosimilar Market Access Key findings from the report, which seeks to reveal opportunities to accelerate biosimilar adoption, include the following: Biosimilar pricing to date has not offered the...

John Greenaway, Jillian Scaife, Nick Simmons-Stern, Ali Haber, and Christina Danosi are traveling to Alexandria, Virginia this week to attend CBI’s Biosimilars Summit. At the conference, they’ll discuss how to overcome reimbursement hurdles in an expanding U.S. biosimilars market. Learn more about...

Todd Foster, Trinity’s director of advanced analytics, will attend the PMSA’s Multi-Channel Marketing Symposium in Las Vegas, January 18 – 19 2018. During the event, Todd will meet with fellow industry leaders to discuss innovative marketing practices that use data to elevate multi-channel marketing for the...

In a recent article for Managed Healthcare Executive, reporter Mari Edlin spoke with Trinity’s John Corcoran about what he sees in the pipeline for 2018 in terms of drug affordability and pharma’s response to the matter. You can read the full...

In a recent article for Formulary Watch, editor Christine Blank spoke with Trinity’s Leslie Sandberg Orne about new blockbuster drugs to hit the marketplace in 2018 that will treat HIV, diabetes, cancer, migraine headaches and other conditions. Check out Leslie’s insights...